Repression of tissue inhibitor of matrix metalloproteinase expression by all‐trans‐retinoic acid in rat bone cell populations: Comparison with transforming growth factor‐βT1
- 1 July 1995
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 164 (1) , 17-25
- https://doi.org/10.1002/jcp.1041640104
Abstract
Retinoids and transforming growth factor‐b̃1 (TGF‐b̃1) reduce the transcriptional activation of matrix metalloproteinases (MMPs) and increase the expression of the specific tissue inhibitor of MMPs (TIMP‐1) in fibroblasts. In contrast, all‐trans‐retinoic acid (retinoic acid) increases MMP expression in osteoblasts. Therefore, the mechanistic aspects of TIMP‐1 regulation by retinoic acid in primary cultures of rat calvarial bone cell populations were studied and compared with those of TGF‐b̃1 to determine if modulation of TIMP‐1 would augment MMP expression. Retionic acid was found to reduce TIMP‐1 mRNA levels after 24 and 72 hr of culture by up to 60% in a dose‐dependent manner. Maximal inhibition occurred at 10−6 M retinoic acid with half maximal repression at ∼5 × 10−8 M. To determine the half life of TIMP‐1 mRNA, the specific RNA polymerase II inhibitor DRB was added to cultures and the chase RNA analyzed by slot blots. TIMP‐1 mRNA had a half life of ∼14 hr and this was unaltered by retinoic acid treatment, suggesting that retinoic acid exerts its effects on TIMP‐1 transcriptionally. When retinoic acid was added to cycloheximide‐treated cultures TIMP‐1 mRNA levels were reduced at 5 hr compared with controls. This showed that ongoing protein synthesis was not required to mediate the retinoic acid repression of TIMP‐1 mRNA levels and supports the evidence that retinoic acid acts at the transcriptional level to reduce TIMP‐1 expression. In contrast, TGF‐b̃1 increased TIMP‐1 mRNA levels by 3.5‐fold at 24 hr to>10‐fold at 72 hr without alterations in mRNA stability indicating that transforming growth factor (TGF)‐b̃1 also acts at the transcriptional level to upregulate TIMP‐1 expression in bone cells. Thus, these studies have revealed that TIMP‐1 regulation by retinoic acid is different in osteoblasts from other cells and that retinoic acid has the property of generating resorptive and formative cell phenotypes in a tissue‐specific manner. In bone, reduced TIMP‐1 expression would favor bone matrix degradation and bone resorption that is a characteristic action of retinoids.Keywords
This publication has 66 references indexed in Scilit:
- The secretion of the tissue inhibitor of metalloproteinases (TIMP) by human synovial fibroblasts is modulated by all-trans-retinoic acidBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Induction of formative and resorptive cellular phenotypes in human gingival fibroblasts by TGF‐β and concanavalin A: Regulation of matrix metalloproteinases and TIMPJournal of Periodontal Research, 1991
- Recent Advances in Matrix Metalloproteinase Research.Trends in Glycoscience and Glycotechnology, 1991
- Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice.Genes & Development, 1990
- Transforming Growth Factor-β Regulation of Collagenase, 72Kda-Progelatinase, Timp and Pai-1 Expression in Rat Bone Cell Populations and Human FibroblastsConnective Tissue Research, 1989
- Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations.The Journal of cell biology, 1988
- A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in cultureBiochemical and Biophysical Research Communications, 1985
- Current views of collagen degeradation. Progress towards understanding the resorption of connective tissuesBioEssays, 1985
- Retinoic Acid Inhibition of Collagenase and Gelatinase Expression in Human Skin Fibroblast Cultures. Evidence for a Dual MechanismJournal of Investigative Dermatology, 1983
- Inhibition by Retinoic Acid of Collagenase Production in Rheumatoid Synovial CellsNew England Journal of Medicine, 1980